Search for: "BAYER PHARMA AG"
Results 1 - 20
of 112
Sorted by Relevance
|
Sort by Date
12 Mar 2012, 3:55 am
Gedeon Richter plc v Bayer Schering Pharma AG [2012] EWCA Civ 235; [2012] WLR (D) 66 “On an application for the revocation of a registered patent on the ground of obviousness it was sufficient for the judge hearing the case to take an objective view whether a skilled formulator would take the trouble to obtain copies of papers published by inventors or review their contents to ascertain whether the patent in question related to an invention which was novel. [read post]
18 Apr 2012, 9:12 pm
By Andrew Williams -- In a second case involving the Hatch-Waxman regulatory scheme decided by the Federal Circuit on Monday, the Court held in Bayer Schering Pharma AG v. [read post]
9 Nov 2017, 9:00 pm
Noonan -- The Federal Circuit reversed a finding of non-obviousness on Friday based on clear error by the District Court on factual underpinnings of its obviousness determination, in Bayer Pharma AG v. [read post]
21 Feb 2010, 8:25 pm
Bayer Schering Pharma AG et al. v. [read post]
7 Mar 2008, 8:19 pm
Bayer Schering Pharma AG v. [read post]
26 Nov 2008, 5:39 pm
This time it's Bayer AG, which allegedly paid medical equipment suppliers to encourage their customers to use Bayer products. [read post]
19 Aug 2012, 11:28 am
Warner Chilcott Company LLC et al. 1:12-cv-01032; filed August 13, 2012 in the District Court of Delaware • Plaintiffs: Bayer Intellectual Property GmbH; Bayer Pharma AG • Defendants: Warner Chilcott Co. [read post]
19 Feb 2012, 8:55 pm
Watson Pharmaceuticals, Inc. et al. 2:12-cv-00223; filed February 13, 2012 in the District Court of Nevada • Plaintiffs: Merck & Cie; Bayer Pharma AG; Bayer Healthcare Pharmaceuticals Inc. [read post]
18 Mar 2012, 8:43 pm
Bayer CropScience AG et al. v. [read post]
8 Jan 2011, 2:18 pm
IN/PCT/2002/410/CHE filed by Bayer Schering Pharma, AG claiming contraceptive formulation of drospirenone and ethinylestradiol (EE) marketed as Yasmin and Yaz/Yasminelle in Europe and the US. [read post]
8 Jan 2011, 2:18 pm
IN/PCT/2002/410/CHE filed by Bayer Schering Pharma, AG claiming contraceptive formulation of drospirenone and ethinylestradiol (EE) marketed as Yasmin and Yaz/Yasminelle in Europe and the US. [read post]
26 Apr 2012, 1:00 am
In Bayer Schering Pharma AG v. [read post]
8 Mar 2016, 9:19 pm
Lupin Ltd. et al. 1:15-cv-00899; filed October 8, 2015 in the District Court of Delaware • Plaintiffs: Merck & Cie; Bayer Pharma AG; Bayer HealthCare Pharmaceuticals Inc. [read post]
30 Oct 2008, 10:14 pm
Big Pharma’s dirty pool tactics don’t just extend to prescription drugs. [read post]
6 Mar 2008, 9:53 pm
Sheridan, presiding) found after a bench trial on all issues that Bayer's U.S. [read post]
19 Aug 2018, 9:59 pm
The '640 and '395 patents are owned by Plaintiffs-Appellees Bayer Intellectual Property GmbH and Bayer Pharma AG. [read post]
9 Oct 2009, 9:11 am
(patent infringement) 9/15: Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc., Schering Corporation v. [read post]
11 Jun 2012, 3:21 am
The Chinese move comes within months of a similar move by India to effectively end the monopoly on an expensive cancer drug made by Bayer AG by issuing its first so-called “compulsory license”. [read post]
27 Jan 2013, 11:59 pm
However, the court has found that Regeneron has engaged in a ‘common design’ with pharmaceutical company Bayer Pharma AG, and its Australian subsidiary Bayer Australia Limited, to undertake actions in Australia that would, on the face of it, infringe the patent. [read post]
6 Feb 2010, 10:14 am
Kazuhiro Sakurada, former Head of Global Drug Discovery Regenerative Medicine Bayer Schering Pharma AG. [read post]
